Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Injection Techniques on Meditoxin Effectiveness in Post-Stroke Spasticity
NCT02757404Phase 4Completed
- Sponsor
- Medytox Inc.
- Start
- May 2016
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of Meditoxin in Spasticity, sponsored by Medytox Inc.. Started May 2016; status: completed.
02
Drugs
Meditoxin
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT02757404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757404.